Stem cells for advanced COPD treatment
Part of Lungs & breathing clinical trials.
This trial tests whether adding umbilical cord stem cells to standard triple therapy can help people with Group E COPD. It aims to see if this approach improves lung function and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 75 years old
- You have Group E COPD (severe symptoms and high risk of flare-ups) and have been on triple inhaler therapy for at least 6 months
- You have not smoked or quit smoking at least 6 months ago
- You have not had a COPD flare-up or infection in the last 2 weeks
- You do not have other serious lung diseases, heart conditions, or uncontrolled health problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special stem cell treatment can help people with moderate to severe COPD when regular medicines are not working well. The treatment may reduce breathing problems and improve quality of life.
This trial tests whether transplanting a patient's own lung stem cells can improve lung function in people with chronic obstructive pulmonary disease (COPD). It aims to see if this treatment is safe and helps repair damaged lung tissue.
This trial is testing a new type of cell therapy called REGEND007 for people with COPD. It looks at whether the treatment can help improve how far you can walk and your overall breathing.
This trial tests whether an infusion of donor stem cells can help people with moderate to severe COPD breathe easier. If you are a current or former smoker aged 40 to 80, your symptoms are stable, and your lung function meets specific targets, you may be able to join.
This study tests a new treatment made from small mobile stem cells, given by inhalation, for people with moderate to severe COPD caused by smoking or pollution. It aims to see if the treatment is safe and helps improve lung function.
This study tests whether a new type of stem cell (SMS cells) can help people with mild or moderate COPD caused by smoking or pollution. You will receive the treatment by inhalation and be followed to see if your breathing improves.
Hear when a new Chronic Obstructive Pulmonary Disease (COPD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.